BPA Call 36E79721A0024-36C26222N0328
Award Date 2/21/22
Potential Completion Date 3/21/22
Potential Value $88K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
KNG OF PRUSSA, PA 19406, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of the pharmaceutical drug HAEGARDA to the Department of Veterans Affairs (VA). The prime contractor is CSL Behring L.L.C., doing business as CSL Behring LLC, a global biotherapeutics company that provides specialty pharmaceuticals to federal agencies. The contract was awarded against CSL Behring's Pharmaceuticals and Drugs Federal Supply Schedule contract managed by the General Services Administration (GSA). The contract has a firm fixed price...
- This federal contract award is for the delivery of HAEGARDA, a treatment for Hereditary Angioedema, to the Department of Veterans Affairs (VA) Veterans Health Administration. The $119,814.22 firm fixed price delivery order was issued against CSL Behring LLC's Pharmaceuticals and Drugs Federal Supply Schedule contract with the General Services Administration (GSA). This contract allows the VA and other agencies to efficiently procure pharmaceutical products through task orders. The award has no...
- This federal contract award is for the delivery of the drug HAEGARDA to the Department of Veterans Affairs (VA) Veterans Health Administration and its regional Veterans Integrated Service Networks. The prime contractor is CSL Behring L.L.C., a global biotherapeutics company focused on developing treatments for rare and serious medical conditions. The contract was awarded on a firm fixed price basis under CSL Behring's Pharmaceuticals and Drugs Federal Supply Schedule contract with the General...
- This federal contract award, valued at $83,173.20, was issued by the U.S. Department of Veterans Affairs (VA) to CSL Behring L.L.C., a global biotherapeutics company, for the supply of HAEGARDA, a C1 inhibitor medication used to treat hereditary angioedema. The contract is a firm fixed-price purchase order without a set-aside designation, indicating CSL Behring is a large, foreign-owned enterprise. CSL Behring holds several multi-year Indefinite Delivery Vehicles (IDVs) with the VA, including...
- This federal contract award is for a delivery order issued to CSL Behring L.L.C., doing business as CSL Behring LLC, by the Department of Veterans Affairs (VA) Veterans Health Administration's Veterans Integrated Service Network 22. The order, valued at $188,118.90, is for the procurement of the Hereditary Angioedema treatment drug HAEGARDA. The contract is awarded under CSL Behring's Pharmaceuticals and Drugs Federal Supply Schedule contract with the General Services Administration (GSA)....
- This federal contract award to CSL Behring L.L.C. (CSL Behring), a global biotherapeutics company, is for the delivery of HAEGARDA 2000U, a medication used to treat Hereditary Angioedema. The $167,217.60 firm fixed price delivery order was placed by the Department of Veterans Affairs (VA) Veterans Health Administration's Veterans Integrated Service Network 22 against CSL Behring's Pharmaceuticals and Drugs Federal Supply Schedule contract managed by the General Services Administration. The award...
- This federal contract award was issued by the Department of Veterans Affairs Veterans Health Administration to CSL Behring L.L.C., a global biotherapeutics company, to provide the Hereditary Angioedema treatment HAEGARDA. The $174,148.50 firm fixed price delivery order was placed against CSL Behring's Pharmaceuticals and Drugs Federal Supply Schedule contract with the General Services Administration. The contract has no set-aside designation and the place of performance is CSL Behring's facility...
- This is a federal contract award to CSL Behring L.L.C., a global biotherapeutics company, by the Department of Veterans Affairs (VA) Veterans Health Administration for the supply of the Hereditary Angioedema treatment HAEGARDA. The contract, valued at $139,344.00, was issued as a Delivery Order against CSL Behring's Pharmaceuticals and Drugs Federal Supply Schedule contract with the General Services Administration (GSA). The contract has a firm fixed price pricing type and does not utilize any...
- This federal contract award was issued by the Department of Veterans Affairs (VA) Veterans Health Administration to CSL Behring L.L.C., doing business as CSL Behring LLC, a global biotherapeutics company. The $208,978.20 firm fixed price delivery order was issued against CSL Behring's Pharmaceuticals and Drugs Federal Supply Schedule contract with the VA and General Services Administration. The contract is to provide the Hereditary Angioedema treatment medication HAEGARDA to VA medical...
- The Department of Veterans Affairs Veterans Health Administration awarded a delivery order to CSL Behring L.L.C. for the supply of HAEGARDA medication, a treatment for Hereditary Angioedema. The $104,510.10 firm fixed price award was placed against CSL Behring's Pharmaceuticals and Drugs Federal Supply Schedule contract with the General Services Administration. The contract has no set-aside designation and the place of performance is CSL Behring's facility in King of Prussia, Pennsylvania. CSL...